Authors:
SCHEULE AM
BEIERLEIN W
JURMAN MJ
WENDEL HP
ECKSTEIN FS
ZIEMER G
Citation: Am. Scheule et al., TIME-COURSE OF APROTININ INDUCED IMMUNE-RESPONSE IS DEPENDENT ON MODEOF APPLICATION, Journal of the American College of Cardiology, 31(2), 1998, pp. 464-464
Authors:
HOFFMEISTER HM
RUF M
WENDEL HP
HELLER W
SEIPEL L
Citation: Hm. Hoffmeister et al., STREPTOKINASE-INDUCED ACTIVATION OF THE KALLIKREIN-KININ SYSTEM AND OF THE CONTACT PHASE IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION, Journal of cardiovascular pharmacology, 31(5), 1998, pp. 764-772
Authors:
SCHEULE AM
BEIERLEIN W
WENDEL HP
ECKSTEIN FS
HEINEMANN MK
ZIEMER G
Citation: Am. Scheule et al., FIBRIN SEALANT, APROTININ, AND IMMUNE-RESPONSE IN CHILDREN UNDERGOINGOPERATIONS FOR CONGENITAL HEART-DISEASE, Journal of thoracic and cardiovascular surgery, 115(4), 1998, pp. 883-889
Authors:
SCHEULE AM
ARNOLD S
BEIERLEIN W
WENDEL HP
ECKSTEIN FS
ZIEMER G
Citation: Am. Scheule et al., APROTININ - PREDICTIVE FACTORS FOR THE PRESENCE OF SPECIFIC ANTIBODIES - A STUDY OF 520 CARDIOSURGICAL PATIENTS, Anesthesia and analgesia, 86(4), 1998, pp. 98-98
Authors:
ECKSTEIN FS
WENDEL HP
HABERLE L
JURMANN MJ
SCHEULE AM
ZIEMER G
Citation: Fs. Eckstein et al., ACUTE DECREASE OF SYSTEMIC VASCULAR-RESISTANCE AFTER RETRANSFUSION OFSHED BLOOD FROM THE PLEURAL CAVITY - MEDIATED BY ACTIVATION OF THE COAGULATION SYSTEM, Anesthesia and analgesia, 86(4), 1998, pp. 107-107
Authors:
HOFFMEISTER HM
RUF M
WENDEL HP
HELBER U
KAZMAIER S
HELLER W
SEIPEL L
Citation: Hm. Hoffmeister et al., ACTIVATION OF THE CONTACT PHASE OF THE COAGULATION, OF THE KININ SYSTEM AND OF THE COMPLEMENT CASCADE BY STREPTOKINASE IN ACUTE MYOCARDIAL-INFARCTION, Fibrinolysis & proteolysis, 11, 1997, pp. 149-152
Citation: U. Bayer et al., THE INFLUENCE OF PREPARATIONS CONTAINING ACETYLSALICYLIC-ACID ON BLOOD-LOSS IN CARDIAC-SURGERY, Thrombosis and haemostasis, 1997, pp. 321-321
Citation: W. Heller et Hp. Wendel, COMPARABLE STUDIES IN THE CONTACT ACTIVATION USING DACRON OR GORETEX VASCULAR PROSTHESIS, Thrombosis and haemostasis, 1997, pp. 777-778
Citation: Cw. Heller et Hp. Wendel, MODEL STUDIES IN THE GENERATION OF THE FACTOR XIIA AND THE CONTACT ACTIVATION BY ACTIVATED PROTEIN, Thrombosis and haemostasis, 1997, pp. 866-866
Authors:
SCHEULE AM
BEIERLEIN W
JUMANN MJ
WENDEL HP
ECKSTEIN FS
ZIEMER G
Citation: Am. Scheule et al., LOW-DOSE TOPICAL AND HIGH-DOSE SYSTEMIC APPLICATION OF APROTININ IN PATIENTS UNDERGOING CARDIAC-SURGERY WITH CARDIOPULMONARY BYPASS - COMPARISON OF THE IMMUNE-RESPONSE, Thrombosis and haemostasis, 1997, pp. 1804-1804
Citation: W. Heller et Hp. Wendel, STUDIES ON THE EFFECT OF SMOKING IN MEN AND SMOKING AND ORAL-CONTRACEPTIVES IN WOMEN ON RISK-FACTORS ON ATHEROSCLEROSIS AND THROMBOSIS, Atherosclerosis, 134(1-2), 1997, pp. 158-158
Authors:
SCHEULE AM
JURMANN MJ
WENDEL HP
HABERLE L
ECKSTEIN FS
ZIEMER G
Citation: Am. Scheule et al., ANAPHYLACTIC SHOCK AFTER APROTININ REEXPOSURE - TIME-COURSE OF APROTININ-SPECIFIC ANTIBODIES, The Annals of thoracic surgery, 63(1), 1997, pp. 242-244
Authors:
SCHULZE HJ
WENDEL HP
KHALIGHI K
HELLER W
SEBOLDT H
Citation: Hj. Schulze et al., THE QUALITY OF AUTOTRANSFUSED CHEST-DRAINAGE BLOOD AFTER CARDIAC-SURGERY - A STUDY OF COAGULATION-FACTORS, The thoracic and cardiovascular surgeon, 44(4), 1996, pp. 183-187
Citation: Hp. Wendel et al., INFLUENCE OF HEPARIN, HEPARIN PLUS APROTININ AND HIRUDIN ON CONTACT ACTIVATION IN A CARDIOPULMONARY BYPASS MODEL, Immunopharmacology, 32(1-3), 1996, pp. 57-61
Citation: Hp. Wendel et al., HEPARIN-COATED DEVICES AND HIGH-DOSE APROTININ OPTIMALLY INHIBIT CONTACT SYSTEM ACTIVATION IN AN IN-VITRO CARDIOPULMONARY BYPASS MODEL, Immunopharmacology, 32(1-3), 1996, pp. 128-130
Authors:
HOFFMEISTER HM
HELBER U
WENDEL HP
HELLER W
Citation: Hm. Hoffmeister et al., DISTURBED HEMOSTASIS AND FIBRINOLYSIS IN UNSTABLE ANGINA-PECTORIS - MORPHOLOGICAL AND PROGNOSTIC ASPECTS, Circulation, 94(8), 1996, pp. 3018-3018
Citation: W. Heller et Hp. Wendel, STUDIES ON EFFICIENCY OF 2 LOW-MOLECULAR-WEIGHT HEPARINS IN MANDIBULAR FACIAL SURGERY, Thrombosis and haemostasis, 73(6), 1995, pp. 979-979
Authors:
HELLER W
WENDEL HP
SCHULZE J
HOFFMEISTER HM
Citation: W. Heller et al., LOWER CARDIAC TROPONIN-T LEVELS IN PATIENTS UNDERGOING CARDIOPULMONARY BYPASS-SURGERY AND RECEIVING HIGH-DOSE APROTININ THERAPY INDICATE REDUCTION IN PERIOPERATIVE MYOCARDIAL DAMAGE, Thrombosis and haemostasis, 73(6), 1995, pp. 1040-1040
Authors:
WENDEL HP
HELLER W
SCHULZE HJ
GALLIMORE MJ
Citation: Hp. Wendel et al., APROTININ ADDS BENEFICIAL-EFFECTS TO HEPARIN-COATED DEVICES REGARDS BLOOD-CELLS AND CONTACT SYSTEM ACTIVATION IN AN IN-VITRO CARDIOPULMONARY BYPASS MODEL, Thrombosis and haemostasis, 73(6), 1995, pp. 1346-1346
Authors:
WENDEL HP
HELLER W
SCHULZE HJ
HOFFMEISTER HE
Citation: Hp. Wendel et al., HIRUDIN SIGNIFICANTLY REDUCES CELLULAR-DAMAGE AND CONTACT SYSTEM ACTIVATION WHEN COMPARED WITH HEPARIN IN AN EX-VIVO CARDIOPULMONARY BYPASSMODEL, Thrombosis and haemostasis, 73(6), 1995, pp. 1454-1454
Authors:
SCHULZE HJ
WENDEL HP
HELLER W
HOFFMEISTER HM
SEBOLDT H
Citation: Hj. Schulze et al., THE INTERNATIONAL NORMALIZED RATIO (INR) AFTER HEART-VALVE REPLACEMENT - A FUTURE STANDARD IN GERMANY, TOO, Herz, Kreislauf, 27(4), 1995, pp. 119-121